Philips Nicol Collimator Family
Philips Medical Systems
FDA Clearance Information
The Philips Nicol Collimator Family was cleared through the FDA 510(k) pathway on March 15, 1999. It is manufactured by Philips Medical Systems and classified as a Class 2 device.
What It Is
FDA-Cleared Indications
- Use with compatible X-ray imaging systems to limit and shape the primary X-ray beam.
- Use during diagnostic and interventional radiographic or fluoroscopic procedures requiring controlled radiation fields.
- Use to support imaging of a selected anatomical region while reducing irradiation of areas outside the region of interest.
Clinical Applications
- Field-size control during fluoroscopically guided vascular procedures.
- Beam limitation during diagnostic radiography and fluoroscopy.
- Imaging support during interventional procedures, including procedures requiring image guidance for targeted treatment.
- Adjustment of the X-ray field to match the anatomy being examined.
Practical Considerations
- The collimator must be used with a compatible X-ray tube, fluoroscopy unit, and imaging system; compatibility depends on the specific model and system configuration.
- Available field sizes, adjustment ranges, light-field alignment, and mounting characteristics vary across the Nicol Collimator Family.
- This is an X-ray accessory, not an MRI device. It should not be taken into the MRI scanner room unless the specific model has been evaluated and labeled as MR Safe or MR Conditional.
- Operators should verify field alignment, shutters, filtration, and system calibration according to the manufacturer’s instructions and institutional quality-control procedures.
- The device does not eliminate radiation risk; dose optimization, shielding, distance, and fluoroscopy-time reduction remain necessary.
Linked Studies (20)
Onyx Liquid Embolic Agent: Basic Knowledge for Its Use in Interventional Neuroradiology.
Journal of neuroendovascular therapy
RCT|prospective|retrospective|case Series|other View Source →Performance evaluation of quantitative hemoglobin A2 and fetal hemoglobin testing using commercially lyophilized vs. in-house whole blood controls in Chinese clinical laboratories: a 12-year analysis of National External Quality Assessment Data.
Clinical chemistry and laboratory medicine
RCT|prospective|retrospective|case Series|other View Source →Clinical progress note: Haemophilus influenzae type b.
Journal of hospital medicine
RCT|prospective|retrospective|case Series|other View Source →Pilot study of social media promotion of home-based self-testing for syphilis.
Sexually transmitted diseases
RCT|prospective|retrospective|case Series|other View Source →Clinical development and performance of the First to Know Syphilis Self-Test for over-the-counter usage: a de novo rapid test for treponemal antibody.
Journal of clinical microbiology
View Source →Implementation of an Opt-Out and Rapid Point-of-Care Syphilis Testing Program for Pregnant Patients Presenting to the Emergency Department.
Sexually transmitted diseases
RCT|prospective|retrospective|case Series|other View Source →Evaluation of Rapid Syphilis Testing Using the Syphilis Health Check in Florida, 2015-2016.
Florida public health review
View Source →Multiplex droplet digital PCR for the detection and quantitation of Streptococcus pneumoniae, Mycoplasma pneumoniae, and Haemophilus influenzae.
Frontiers in cellular and infection microbiology
RCT|prospective|retrospective|case Series|other View Source →Palm Multidiagnostic of Mycoplasma pneumoniae, Chlamydia pneumoniae, Haemophilus influenzae, and Streptococcus pneumoniae Using One-Tube CRISPR/Cas12a.
Transboundary and emerging diseases
View Source →Tp40: a new potential prognostic and diagnostic marker for syphilis.
Microbiology spectrum
View Source →Serotonin sets up neutrophil extracellular traps to promote neuroendocrine prostate cancer metastasis in the liver.
The Journal of clinical investigation
RCT|prospective|retrospective|case Series|other View Source →Application value of Philips Ingenuity TF PET/CT scanner imaging agent FAP in evaluating renal fibrosis.
Hellenic journal of nuclear medicine
RCT|prospective|retrospective|case Series|other View Source →Message from Dr. Philippe T. Georgel, Guest Editor for the Marshall University Collection, Brad D. Smith, President of Marshall University, and Dr. Anivandan Mukherjee, Provost of Marshall University.
Biochemistry and cell biology = Biochimie et biologie cellulaire
View Source →Improved patient comfort and procedural efficiency using chlorhexidine-coated hydrophilic urethral catheters: a randomized controlled trial.
Journal of Yeungnam medical science
RCT View Source →pTx-Pulseq in hybrid sequences: Accessible and advanced hybrid open-source MRI sequences on Philips scanners.
Magnetic resonance in medicine
RCT|prospective|retrospective|case Series|other View Source →Comparative connectomics of Drosophila descending and ascending neurons.
Nature
RCT|prospective|retrospective|case Series|other View Source →Hydrophilic-coated sheaths for reducing radial artery spasm during transradial procedures: A systematic review and meta-analysis.
Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences
View Source →History of antineutrophil cytoplasmic autoantibodies : Milestones in rheumatology.
Zeitschrift fur Rheumatologie
View Source →A Hydrophilic Polyurethane Foam Containing Nigella sativa Oil as a Wound Dressing.
BioMed research international
RCT|prospective|retrospective|case Series|other View Source →Frequently Asked Questions
What is the Philips Nicol Collimator Family used for?
It is used to shape and focus X-ray beams during radiological procedures, enhancing imaging precision and reducing unnecessary radiation exposure.
What specialties typically use this device?
Radiologists and interventional specialists commonly use this device, particularly in hospital radiology departments.
What are the FDA-cleared indications?
The device is indicated for use in procedures requiring precise imaging, such as embolization with liquid agents, to improve targeting and reduce radiation exposure.